
|Videos|December 19, 2022
Institutional Perspectives in Neurology, Chaired by Robert Bermel, MD
Author(s)NeurologyLive® Staff
Chaired by Robert Bermel, MD, of Cleveland Clinic, the presentations also feature Jeffrey Cohen, MD; Amy Kunchock, MBBS, MMed; and Brandon Moss, MD. [WATCH TIME: 1 hour, 30 minutes]
Advertisement
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
TOPICS INCLUDE:
- 03:30 – PIRA is the Major Contributor to MS Disability — Robert Bermel, MD
- 21:45 – Autologous Hematopoietic Stem Cell Transplantation — Jeffrey Cohen, MD
- 43:40 – Question & Answer
- 46:25 – Update on NMO and MOGAD — Amy Kunchok, MBBS, MMed
- 1:03:30 – Management of MS through COVID-19 — Brandon Moss, MD
- 1:19:40 – Question & Answer
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Cladribine Tablets Show Ability to Improve or Stabilize Cognitive Function in Patients With Relapsing Multiple Sclerosis
2
Cladribine Maintains Efficacy, Safety Profile in Older Patients With Multiple Sclerosis
3
Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers
4
CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis
5










